EntryPoint Capital’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$549K Buy
+1,036
New +$478K 0.13% 295
2025
Q4
Sell
-888
Closed -$457K 790
2025
Q3
$457K Buy
888
+69
+8% +$30.1K 0.18% 198
2025
Q2
$257K Sell
819
-31
-4% -$9.31K 0.13% 359
2025
Q1
$259K Sell
850
-653
-43% -$220K 0.12% 411
2024
Q4
$499K Buy
1,503
+605
+67% +$205K 0.21% 105
2024
Q3
$300K Buy
898
+582
+184% +$221K 0.17% 250
2024
Q2
$130K Buy
316
+183
+138% +$72.5K 0.06% 658
2024
Q1
$53.8K Buy
+133
New +$46.8K 0.05% 723

Other funds holding MEDP

EntryPoint Capital's MEDP Position: Q2 2026 in Review

EntryPoint Capital opened a new position in Medpace (MEDP) in Q2 2026: 1,036 shares worth $549K. The stake represents 0.13% of the portfolio and ranks #295 among its holdings. This is a return to the name: EntryPoint Capital previously reported a position in MEDP as recently as Q3 2025.

EntryPoint Capital first reported a position in MEDP in Q1 2024 and has held it in 8 quarters since. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • EntryPoint Capital held 1,036 shares of Medpace worth $549K as of Q2 2026.
  • Medpace was a new EntryPoint Capital position in Q2 2026.
  • Medpace made up 0.13% of EntryPoint Capital's portfolio in Q2 2026, its #295 holding.
  • EntryPoint Capital first reported a position in Medpace in Q1 2024 and has held it in 8 quarters since.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.